Synthesis, Anticancer Activity, and Docking Studies of Novel Hydroquinone-Chalcone-Pyrazoline Hybrid Derivatives
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25137281 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Javier Maldonado und 4 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Química, Facultad de Ciencias, Pontificia Universidad Católica de Valparaíso, Valparaíso 23732223, Chile. Hauptthemen laut MEDLINE: Molecular Docking Simulation, Antineoplastic Agents, Pyrazoles, Hydroquinones. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dirección de Investigación de la Vicerrectoría de Investigación y Estudios Avanzados, FONDEQUIP, Doctoral Fellowship CONICYT- PCHA/Doctorado Nacional/.
Abstract (Originalsprache)
A novel series of antitumor hybrids was synthesized using 1,4-benzohydroquinone and chalcone, furane, or pyrazoline scaffolds. This were achieved through isosteric substitution of the aryl group of the chalcone β-carbon with the furanyl moiety and structural modification of the α,β-unsaturated carbonyl system. The potential antitumor activity of these hybrids was evaluated in vivo on MCF-7 breast adenocarcinoma and HT-29 colorectal carcinoma cells, demonstrating cytotoxic activity with IC50 values ranging from 28.8 to 124.6 µM. The incorporation of furan and pyrazoline groups significantly enhanced antiproliferative properties compared to their analogues and precursors (VII–X), which were inactive against both neoplastic cell lines. Compounds 4, 5, and 6 exhibited enhanced cytotoxicity against both cell lines, whereas compound 8 showed higher cytotoxic activity against HT-29 cells. Molecular docking studies revealed superior free-energy values (ΔGbin) for carcinogenic pathway-involved kinase proteins, with our in silico data suggesting that these derivatives could be promising chemotherapeutic agents targeting kinase pathways. Among all the synthesized PIBHQ compounds, derivatives 7 and 8 exhibited the best drug-likeness properties, with values of 0.53 and 0.83, respectively. ADME results collectively suggest that most of these compounds hold promise as potential candidates for preclinical assays.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Instituto de Química, Facultad de Ciencias, Pontificia Universidad Católica de Valparaíso, Valparaíso 23732223, Chile.
ORCID-Profile: Javier Maldonado, Leda Guzmán, Aurora Molinari, Waldo Acevedo
Förderung
- Dirección de Investigación de la Vicerrectoría de Investigación y Estudios Avanzados
- FONDEQUIP
- Doctoral Fellowship CONICYT- PCHA/Doctorado Nacional/
- Dirección de Investigación de la Vicerrectoría de Investigación y Estudios Avanzados, Pontificia Universidad Católica de Valparaíso, Chile
- HPC OCÉANO
- supercomputing infrastructure of the NLHPC
- Doctoral Fellowship CONICYT- PCHA/Doctorado
Zitieren
APA
Maldonado, J., Oliva, A., Guzmán, L., Molinari, A., & Acevedo, W. (2024). Synthesis, Anticancer Activity, and Docking Studies of Novel Hydroquinone-Chalcone-Pyrazoline Hybrid Derivatives. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25137281
Vancouver
Maldonado J, Oliva A, Guzmán L, Molinari A, Acevedo W. Synthesis, Anticancer Activity, and Docking Studies of Novel Hydroquinone-Chalcone-Pyrazoline Hybrid Derivatives. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25137281
BibTeX
@article{Maldonado2024,
author = {Maldonado, Javier and Oliva, Alfonso and Guzmán, Leda and Molinari, Aurora and Acevedo, Waldo},
title = {Synthesis, Anticancer Activity, and Docking Studies of Novel Hydroquinone-Chalcone-Pyrazoline Hybrid Derivatives},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25137281}
}
EUVIMED